Quantification of D2-like dopamine receptors in the human brain with 18F-desmethoxyfallypride

Journal of Nuclear Medicine

Volumn 44, Issue 1, 2003, Pages 109-116

  Gründer, Gerhard ^a   Siessmeier, Thomas ^a   Piel, Markus ^a   Vernaleken, Ingo ^a   Buchholz, Hans Georg ^a   Zhou, Yun ^b   Hiemke, Christoph ^a   Wong, Dean F ^b   Rösch, Frank ^a   Bartenstein, Peter ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

^b NONE

Author keywords

18F desmethoxyfallypride; Caudate nucleus; D2 like dopamine receptors; PET; Putamen; Thalamus

Indexed keywords

AMISULPRIDE; BENZAMIDE; BENZAMIDE DERIVATIVE; DESMETHOXYFALLYPRIDE F 18; DOPAMINE 2 RECEPTOR; LIGAND; SPIPERONE; TRACER; TRITIUM; UNCLASSIFIED DRUG; DESMETHOXYFALLYPRIDE; DIAGNOSTIC AGENT; RADIOPHARMACEUTICAL AGENT; SALICYLAMIDE DERIVATIVE;

ADULT; ANALYTIC METHOD; ANIMAL TISSUE; ARTICLE; CEREBELLUM; CONTROLLED STUDY; CORPUS STRIATUM; CYCLOTRON; DISTRIBUTION VOLUME; DRUG UPTAKE; HUMAN; HUMAN EXPERIMENT; IMAGE ANALYSIS; ISOTOPE LABELING; MALE; NONHUMAN; NORMAL HUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; QUANTITATIVE ASSAY; RAT; RECEPTOR AFFINITY; RECEPTOR BINDING; RECEPTOR DENSITY; RELIABILITY; SCHIZOPHRENIA; THALAMUS; ANIMAL; BIOLOGICAL MODEL; BLOOD; BRAIN; CLINICAL TRIAL; COMPARATIVE STUDY; COMPUTER ASSISTED EMISSION TOMOGRAPHY; IN VITRO STUDY; METABOLISM; SCINTISCANNING; TISSUE DISTRIBUTION;

ADULT; ANIMALS; BRAIN; HUMANS; MALE; MODELS, BIOLOGICAL; RADIOPHARMACEUTICALS; RATS; RECEPTORS, DOPAMINE D2; SALICYLAMIDES; SCHIZOPHRENIA; TISSUE DISTRIBUTION; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0037267885     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Wagner HN Jr, Burns HD, Dannals RF, et al. Assessment of dopamine receptor densities in the human brain with carbon-11-labeled N-methylspiperone. Ann Neurol. 1984;15(suppl):S79-S84.
2. Wong DF, Young D, Wilson PD, Meltzer CC, Gjedde A. Quantification of neuroreceptors in the living human brain. III. D2-like dopamine receptors: theory, validation, and changes during normal aging. J Cereb Blood Flow Metab. 1997; 17:316-330.
3. Wong DF, Pearlson GD, Tune LE, et al. Quantification of neuroreceptors in the living human brain. IV. Effect of aging and elevations of D2-like receptors in schizophrenia and bipolar illness. J Cereb Blood Flow Metab. 1997;17:331-342.
4. Farde L, Hall H, Ehrin E, Sedvall G. Quantitative analysis of D2 dopainine receptor binding in the living human brain by PET. Science. 1986;231:258-261.
5. 2A receptor occupancy in the human brain after a single oral dose of the putative antipsychotic drug MDL 100,907 measured by positron emission tomography [published correction appears in Neurolpsychopharmacology. 1998;19:161]. Neuropsychopharmacology. 1997;17:175-185.
6. Andrée B, Nyberg S, Ito H, et al. Positron emission tomographic analysis of dose-dependent MDL 100,907 binding to 5-hydroxytryptamine-2A receptors in the human brain. J Clin Psychopharmacol. 1998;18:317-323.
7. 123I]IBZM: a potential CNS D-2 dopamine receptor imaging agent. J Nucl Med. 1989;30:88-92.
8. 2 receptors in the human brain. Eur J Pharmacol. 1992;223:105-107.
9. 2 dopamine receptors. J Nucl Med. 1995;36:1275-1281.
10. 2 receptors. Life Sci. 1996;59: 669-678.
11. 18F-fallypride in nonhuman primates using positron emission tomography. Synapse. 1997;27:1-13.
12. Mukherjee J, Yang Z-Y, Brown T, et al. Potential anomalies of dopamine D-2 receptor: challenges for non-invasive imaging studies by positron emission tomography. Med Chem Res. 1994;5:174-192.
13. 18F]-fluoro-2-deoxy-D-glucose using aminopolyether supported nucleophilic substitution. J Nucl Med. 1986;27:235-238.
14. Hiemke C, Ghraf R. Interaction of non-steroidal antiestrogens with dopamine receptor binding. J Steroid Biochem. 1984;21:663-667.
15. Woods RP, Cherry SR, Mazziotta JC. Rapid automated algorithm for aligning and reslicing PET images. J Comput Assist Tomogr. 1992;16:620-633.
16. 123]iodosulpride. Neuroscience. 1987;20:117-155.
17. 11C]flumazenil kinetics for the estimation of ligand transport rate and receptor distribution using positron emission tomography. J Cereb Blood Flow Metab. 1991;11:735-744.
18. Zhou Y, Endres CJ, Dogan AS, Brasic JR, Huang S-C, Wong DF. A new linear parametric imaging algorithm derived from simplified reference tissue model for ligand-receptor dynamic PET studies. In: Senda M, Kimura Y, Herscovitch P, eds. Brain Imaging Using PET. San Diego, CA: Academic Press; 2002:31-37.
19. 11C]raclopride studies. J Cereb Blood Flow Metab. 1996;16:42-52.
20. 11C]carfentanil binding to opiate receptors in humans measured by positron emission tomography. J Cereb Blood Flow Metab. 1989;9:398-409.
21. 11C-methyl]-(-)-cocaine PET studies in human subjects. J Cereb Blood Flow Metab. 1990;10: 740-747.
22. Logan J, Fowler JS, Volkow ND, Wang GJ, Ding YS, Alexoff DL. Distribution volume ratios without blood sampling from graphical analysis of PET data. J Cereb Blood Flow Metab. 1996;16:834-840.
23. Lammertsma AA, Hume SP. Simplified reference tissue model for PET receptor studies. Neuroimage. 1996;4:153-158.
24. Farde L, Eriksson L, Blomquist G, Halldin C. Kinetic analysis of central [UC]raclopride binding to D2-dopamine receptors studied by PET: a comparison to the equilibrium analysis. J Cereb Blood Flow Metab. 1989;9:696-708.
25. Högberg T, Rämsby S, Ström P. Efficient stereoconservative syntheses of 1-substituted (S)- and (R)-2-aminomethylpyrrolidines. Acta Chem Scand. 1989;43: 660-664.
26. 18F]benzamide neuroleptic [published correction appears in Eur J Pharmacol. 1990;187:143]. Eur J Pharmacol. 1990;175:363-364.
27. 3H-raclopride: a potent substituted benzamide drug with high affinity for dopamine D-2 receptors in the rat brain. Biochem Pharmacol. 1985;34:2251-2259.
28. 3H]raclopride to rat and human brain membranes. J Neurochem. 1990;55:2048-2057.
29. 11C]raclopride: PET with anatomic standardization technique. Neuroimage. 1999;9:235-242.
30. Ariano MA, Kang HC, Haugland RP, Sibley DR. Multiple fluorescent ligands for dopamine receptors. II. Visualization in neural tissues. Brain Res. 1991;547:208-222.
31. De Souza EB. Serotonin and dopamine receptors in the rat pituitary gland: autoradiographic identification, characterization, and localization. Endocrinology. 1986;119:1534-1542.
32. 3H]SCH23390. Neuroscience. 1991;40:657-671.
33. Richfield EK, Young AB, Penney JB. Comparative distribution of dopamine D-1 and D-2 receptors in the basal ganglia of turtles, pigeons, rats, cats, and monkeys. J Comp Neurol. 1987;262:446-463.
34. Wang GJ, Volkow ND, Fowler JS, et al. Comparison of two PET radioligands for imaging extrastriatal dopamine receptors in the human brain. Synapse. 1993;15: 246-249.
35. 2 receptors in thalamus and in temporal insula of human subjects. Life Sci. 1996;59:PL31-PL35.
36. 2 receptors in striatum and anterior cingulate gyrus in major depression. Neuroimage. 1997;5:251-260.
37. 18F-fallypride. Nucl Med Biol. 1999;26:519-527.
38. 11C]FLB 457 binding to extrastriatal D2-dopamine receptors in healthy subjects and antipsychotic drug-treated patients. Psychopharmacology (Berl). 1997;133:396-404.
39. 18F]fallypride [abstract]. J Nucl Med. 2000;41(suppl):139P.